Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 31722-522, Hydralazine Hydrochloride, tablet, from Camber Pharmaceuticals, Inc..

Product NDC
31722-522
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040901
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-522 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
31722-522-0131722052201100 TABLET in 1 BOTTLE (31722-522-01)
31722-522-0531722052205500 TABLET in 1 BOTTLE (31722-522-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5da36930-d3da-4b5c-9e22-2b141bc01a9c
  • NADAC price for package 31722052201

    GET /v1/drugs/nadac/31722052201
  • NADAC price for package 31722052205

    GET /v1/drugs/nadac/31722052205

Use it

Look up 31722-522 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-522 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-522. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.